Literature DB >> 1457661

Cryptosporidiosis in patients infected with the human immunodeficiency virus.

C Petersen1.   

Abstract

Infection caused by Cryptosporidium species has proved to be one of the most taxing and frustrating conditions faced by clinicians caring for patients with AIDS. Unfortunately, this unique organism, which was identified as a human pathogen only shortly before the AIDS epidemic began to manifest itself, has received only minimal attention during the past decade. Dr. Carolyn Petersen, an assistant professor of medicine at the University of California, San Francisco, and a member of the Division of Infectious Diseases at San Francisco General Hospital, is a molecular parasitologist whose investigative career is focused on elucidating the biology of Cryptosporidium species. In this AIDS Commentary Dr. Petersen provides an update on recent developments in this field.

Entities:  

Mesh:

Year:  1992        PMID: 1457661     DOI: 10.1093/clind/15.6.903

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  36 in total

Review 1.  Passive immunity against human pathogens using bovine antibodies.

Authors:  C Weiner; Q Pan; M Hurtig; T Borén; E Bostwick; L Hammarström
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

Review 2.  Cryptosporidiosis in persons with HIV infection.

Authors:  B Ramratnam; T P Flanigan
Journal:  Postgrad Med J       Date:  1997-11       Impact factor: 2.401

3.  Cryptosporidiosis and inflammatory bowel disease. Experience from the Milwaukee outbreak.

Authors:  M W Manthey; A B Ross; K H Soergel
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

4.  Cloning and sequence analysis of a highly polymorphic Cryptosporidium parvum gene encoding a 60-kilodalton glycoprotein and characterization of its 15- and 45-kilodalton zoite surface antigen products.

Authors:  W B Strong; J Gut; R G Nelson
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

5.  CryptoDB: the Cryptosporidium genome resource.

Authors:  Daniela Puiu; Shinichiro Enomoto; Gregory A Buck; Mitchell S Abrahamsen; Jessica C Kissinger
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

6.  Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection.

Authors:  F J Enriquez; M W Riggs
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo.

Authors:  P S Doyle; J Crabb; C Petersen
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

Review 8.  Human antiprotozoal therapy: past, present, and future.

Authors:  M Khaw; C B Panosian
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

9.  Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice.

Authors:  M W Riggs; V A Cama; H L Leary; C R Sterling
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

10.  Cryptosporidium parvum initiates inflammatory bowel disease in germfree T cell receptor-alpha-deficient mice.

Authors:  R E Sacco; J S Haynes; J A Harp; W R Waters; M J Wannemuehler
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.